Showing results (41-50 of 128) with videos related to

Sort By:
Pageof 13
Cancer Investigation|December 13, 2006
Role of carbonic anhydrases in the progression of renal cell carcinoma subtypes: proposal of a unified hypothesisThambi Dorai, Ihor Sawczuk, Jaromir Pastorek, et al.
Medical Oncology (Northwood, London, England)|December 17, 2002
Microangiopathic hemolysis refractory to plasmapheresis responding to docetaxel and cisplatin: a case reportGeorge Marcoullis, Lool Abebe, Dharamvir Jain, et al.
European Journal of Cancer (Oxford, England : 1990)|November 29, 2005
The role of carbonic anhydrase IX overexpression in kidney cancerThambi Dorai, Ihor S Sawczuk, Jaromir Pastorek, et al.
Dermatology Online Journal|September 10, 2005
Unusually large colon cancer cutaneous and subcutaneous metastases occurring in resection scarsDoru T Alexandrescu, Juan Vaillant, Laura J Yahr, et al.
Medical Oncology (Northwood, London, England)|August 22, 2009
A pilot study of carboplatin and mitoxantrone in blast crisis of chronic myeloid leukemiaJanice P Dutcher, Evelyn L Morris, Bruce Gaynor, et al.
Cancer|September 16, 2004
Idarubicin and standard-dose cytosine arabinoside in adults with recurrent and refractory acute lymphocytic leukemiaMerat Karbasian-Esfahani, Peter H Wiernik, Yelena Novik, et al.
British Journal of Haematology|February 12, 2004
Cardiac monitoring of patients receiving arsenic trioxide therapyDilip Unnikrishnan, Janice P Dutcher, Susan Garl, et al.
Journal of Clinical Pharmacology|May 4, 2018
Core Entrustable Professional Activities in Clinical Pharmacology for Entering Residency: Value of Interprofessional Health-Care Teams in Medication Prescribing and Medication Error PreventionLawrence J Cohen, Vera S Donnenberg, Peter H Wiernik, et al.
American Journal of Hematology|February 24, 2005
Strokes after intravenous gamma globulin: thrombotic phenomenon in patients with risk factors or just coincidence?Doru T Alexandrescu, Janice P Dutcher, John T Hughes, et al.
Medical Oncology (Northwood, London, England)|January 13, 2004
Probable veno-occlusive disease after treatment with gemtuzumab ozogamicin in a patient with acute myeloid leukemia and a history of liver transplantation for familial hemochromatosisKevin P O'Boyle, Ashwin Murigeppa, Dharamvir Jain, et al.
Pageof 13